-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637A.O2.6 637. Myelodysplastic Syndromes – Clinical Studies: New Therapeutic Approaches

Myelodysplastic Syndromes – Clinical Studies Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 5, 2015: 12:00 PM-1:30 PM
W331, Level 3 (Orange County Convention Center)
Moderators:
David P. Steensma, MD, Dana-Farber Cancer Institute and Raphael Itzykson, MD PhD, Saint-Louis Hospital

Disclosures:
Steensma: Celgene: Consultancy ; Amgen: Consultancy ; Incyte: Consultancy ; Onconova: Consultancy .
12:00 PM

Esther Natalie Oliva, MD1, Valeria Santini, MD2, Caterina Alati, MD1*, Antonella Poloni, MD3*, Alfredo Molteni, MD4*, Pasquale Niscola, MD5*, Grazia Sanpaolo, MD6*, Flavia Salvi, MD7*, Giuseppe A. Palumbo, MD8*, Enrico Balleari, MD9*, Stefana Impera, MD10*, Agostino Cortelezzi, MD11, Anna Marina Liberati, MD12*, Paolo Avanzini, MD13*, Paolo Di Bartolomeo, MD14, Christian Rose15, Odile Beyne-Rauzy, MD, PhD16*, Francesco Buccisano, MD,17, Monica Bocchia, MD18*, Fortunato Morabito, MD19*, Aspasia Stamatoullas, MD20*, Francesca Ronco1*, Gina Zini, MD, Prof.21, Maria Grazia D'Errigo22*, Natale Ranieri, MD1*, Patrizia Cufari1*, Irene Santacaterina, MD1*, Pierre Fenaux, MD, PhD23 and Roberto Latagliata, MD24*

1Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
2AOU Careggi, University of Florence, Florence, Italy
3Haematology Clinic, Ospedali Riuniti di Ancona, Ancona, Italy
4Ospedale Niguarda, Milano, Italy
5Department of Hematology, “S. Eugenio Hospital”, Rome, Italy
6Hematology, Istituto Casa del Sollievo della Sofferenza, San Giovanni Rotondo, Italy
7Hematology, “SS Antonio e Biagio” Hospital, Alessandria, Italy
8Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy
9Genova Hospital, Genova, Italy
10Section of Hematology, A.R.N.A.S. Garibaldi Nesima, Catania, Italy
11Oncohematology Unit, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
12SC Oncoematologia, Azienda Ospedaliera S. Maria, Terni, Italy
13Hematology, S.Maria Nuova Hospital, Reggio Emilia, Italy
14Dipartimento Ematologia, Ospedale Civile Santo Spirito, Pescara, Italy
15Dept. of Hematology, Hopital St. Vincent, Lille, France
16Service de medecine Interne, CHU Purpan, Toulouse, France
17Hematology, University Tor Vergata, Rome, Italy
18Department of Hematology and Transplants, University of Siena, Siena, Italy
19Section of Hematology, A.O. L'Annunziata of Cosenza, Cosenza, Italy
20Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
21Centro di Ricerca ReCAMH, Hematology, Catholic University of the Sacred Heart, Rome, Italy
22Genetics Laboratory, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
23Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
24Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy

12:15 PM

Aristoteles Giagounidis, MD, PhD1, Uwe Platzbecker, MD2, Ulrich Germing, MD3*, Katharina Götze, MD4*, Philipp Kiewe, MD5*, Karin Tina Mayer, MD6*, Oliver Ottmann, MD7, Markus Radsak, MD8*, Thomas Wolff, MD9, Detlef Haase, MD10*, Monty Hankin11*, Dawn Wilson11*, Xiaosha Zhang11*, Adberrahmane Laadem, MD12, Matthew L. Sherman, MD11 and Kenneth M. Attie, MD11

1Marien Hospital Düsseldorf, Düsseldorf, Germany
2Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany
3Universitätsklinikum Düsseldorf, Düsseldorf, Germany
4Technical University of Munich, Munich, Germany
5Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin, Germany
6Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany
7Universitätsklinikum Frankfurt, Goethe Universitaet, Frankfurt/Main, Germany
8University Medical Center - Johannes Gutenberg-Universität, Mainz, Germany
9OncoResearch Lerchenfeld UG, Hamburg, Germany
10Department of Hematology and Medical Oncology, Universitätsmedizin Göttingen, Göttingen, Germany
11Acceleron Pharma, Cambridge, MA
12Celgene Corporation, Summit, NJ

12:30 PM

Gautam Borthakur, MD1, James M. Foran, MD2, Eunice S. Wang, MD3, Amol Rakkar4*, Hans Minderman5*, Jennifer Burns6*, Michael Andreeff, MD, PhD1 and Raoul Tibes, MD, PhD7

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Mayo Clinic Cancer Center, Jacksonville, FL
3Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
4Palo Verde Hematology-Oncology, Ltd., Glendale, AZ
5Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, NY
6TetraLogic Pharmaceuticals, Malvern, PA
7Hematology Oncology/ Blood and Marrow Transplant, Mayo Clinic Arizona, Phoenix, AZ

12:45 PM

Nicholas J. Short, MD1, Guillermo Garcia-Manero, MD1, Guillermo Montalban Bravo, MD1*, Koji Sasaki, MD1, Mikkael A. Sekeres, MD, MS2, Rami S. Komrokji, MD3, David P. Steensma, MD4, Amy E. DeZern, MD, MHS5, Gail J Roboz, MD6, Tapan Kadia, MD1, Gautam Borthakur, MD1, Courtney DiNardo, MD1, Darla Miller1*, Zeev Estrov, MD1, Naveen Pemmaraju, MD1, Naval Daver, MD1, Srdan Verstovsek, MD, PhD1, Hagop M. Kantarjian, MD1 and Elias Jabbour1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Leukemia Program, Cleveland Clinic, Cleveland, OH
3Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL
4Dana-Farber Cancer Institute, Boston, MA
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
6Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY

1:00 PM

Thomas Prebet, MD1, Thomas Cluzeau, MD, PhD2*, Sophie Park, MD, PhD3, Ulrich Germing, MD4*, Lionel Ades, MD, PhD5,6, Uwe Platzbecker, MD7, Norbert Vey8, Katharina Goetze, MD9*, Charikleia Kelaidi, MD10,11*, Esther Natalie Oliva12, Najla H. Al Ali, BDS, MSc13*, Pierre Fenaux, MD, PhD14,15, Steven D. Gore, MD16 and Rami S. Komrokji, MD13

1Dept of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
2H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3CHU de Grenoble, Clinique Universitaire d’Hématologie, Université Joseph Fourier, Grenoble Cedex 9, France
4Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
5Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France
6GFM, Hôpital Saint Louis, Paris, France
7Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
8Hematology, Institut Paoli-Calmettes, Marseille, France
9Technische Universität München, München, Germany
10hôpital saint louis, groupe francophone des myelodysplasies, Paris, France
11Hopital Avicenne -Paris 13 University, Bobigny, France
12A.O. Bianchi-Melacrino-Morelli, Hematology, Reggio Calabria, Italy
13Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
14Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
15Groupe Francais des myélodysplasies (GFM), Paris, France
16Yale Cancer Center, New Haven, CT

1:15 PM

Cindy Medina, B.S.1*, Leylah Drusbosky, BS1*, Myron Chang, PhD2*, Shireen Vali3*, Ansu Kumar4*, Neeraj Kumar Singh4*, Taher Abbasi3*, Mikkael A. Sekeres, MD, MS5, Mar Mallo, PhD6*, Francesc Sole, PhD6, Rafael Bejar, MD, PhD7 and Christopher R. Cogle, M.D.1

1Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL
2Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL
3Cellworks Group Inc., 2033 Gateway Place Suite 500, San Jose, CA
4Cellworks Group, Inc., San Jose, CA
5Leukemia Program, Cleveland Clinic, Cleveland, OH
6MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
7UCSD Moores Cancer Center, La Jolla, CA

*signifies non-member of ASH